“The Baby Lottery” Coming Soon to Poor Countries Around the World

Ropi via ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

I try not to go too far overboard in our communal loathing of pharmaceutical companies, but they sure do make it hard sometimes:

Novartis AG launched a lottery-style program to give away doses of its pricey gene therapy for free, drawing criticism from patient groups that say that is an inappropriate way to distribute a lifesaving treatment aimed at babies.

Zolgensma, a one-shot cure for a deadly inherited disease whose victims cannot control their muscles, is so far sold only in the U.S. at a price of $2.1 million, making it the world’s most expensive drug….Under the program, doctors can submit requests for the treatment, with eligible patients entered into a draw every two weeks for free doses. AveXis, the Novartis unit that makes the drug, said it aimed to distribute around 100 free doses a year as long as production capacity allows.

This is not just sort of like The Hunger Games, it’s pretty much exactly like The Hunger Games. A rich corporation draws names of babies out of a hat, and every two weeks a lucky baby from a poor country gets to live. Then the drudges all go back to work and dream about the next lottery. All that’s missing are the outlandish costumes.

Meanwhile, in the US there’s no lottery. Your baby lives if you or your insurance company is willing to shell out $2.1 million. That’s a lottery too, but not quite such an obvious one.

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate